Unlock instant, AI-driven research and patent intelligence for your innovation.
2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
a technology of 2-phenyl-1-benzyl and estrogen, which is applied in the direction of drug compositions, biocide, heterocyclic compound active ingredients, etc., can solve the problems of increasing the risk of endometriosis and/or endometrial cancer
Inactive Publication Date: 2007-06-14
WYETH LLC
View PDF29 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Benefits of technology
The present invention provides pharmaceutical formulations and methods of using compounds of formulas (I) and (II) in combination with estrogens to alleviate symptoms of post-menopausal syndrome in women. The compounds are estrogen agonists / antagonists that can show little uterine stimulation and can minimize the amount of estrogen needed. The use of these compounds in combination with estrogens can also help reduce the side effects of estrogen treatment. The patent also includes methods of using the compounds alone or in combination with other pharmaceutical carriers or excipients.
However, it is also a partial agonist in the uterus and this is cause for some concern.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
example no.1 2
Example No. 1 2-Phenyl-3-methyl-1H-indole
[0068] Mp=90-94° C.; 1H NMR (DMSO) 11.13 (s, 1H), 7.68-7.64 (m, 2H), 7.54-7.46 (m, 3H), 7.37-7.32 (m, 2H), 7.12-7.06 (m, 1H), 7.03-6.97 (m, 1H), 2.40 (s, 3H); MS eI m / z 207 (M+).
Example No. 1a 5-Flouro-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole Mp=143-146° C.
example no.2 2
Example No. 2 2-(4-Benzyloxy-phenyl)-3-methyl-1H-indole
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Property
Measurement
Unit
melting point
aaaaa
aaaaa
melting point
aaaaa
aaaaa
melting point
aaaaa
aaaaa
Login to View More
Abstract
The present invention relates to new formulations containing one or more estrogens and 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole compounds which are useful as estrogenic agents, as well as pharmaceutical compositions and methods of treatment utilizing these compounds, which have the general structures below:
Description
[0001] This application claims the benefit of U.S. Provisional Application No. 60 / 109,809, which was converted from U.S. patent application Ser. No. 09 / 079,561, filed May 15, 1998, pursuant to a petition filed under 37 C.F.R. 1.53(c)(2)(i).[0002] The present invention relates to the use of new 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole compounds which are useful as estrogenic agents, in conjunction with estrogens, as well as pharmaceutical compositions and methods of treatment utilizing these compounds. BACKGROUND OF THE INVENTION [0003] The use of hormone replacement therapy for bone loss prevention in post-menopausal women is well precedented. The normal protocol calls for estrogen supplementation using such formulations containing estrone, estriol, ethynyl estradiol, 17β-estradiol, esterified estrogens, or conjugated estrogens isolated from natural sources (i.e. Premarin® conjugated estrogens from Wyeth-Ayerst) or synthetic estrogens. In some patients, therapy may be contraindi...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More
Patent Type & Authority Applications(United States)